Its natural to wonder: How do these peptide therapies compare to GLP-1 agonists like semaglutide (Ozempic) or tirzepatide (the dual agonist Mounjaro)
Most patients apply it in the morning or at night based on their routine
Comprehensive monitoring should include assessment of therapeutic response and screening for potential adverse effects, particularly signs of malignancy given the angiogenic effects
There are oral tablets or capsules, sublingual applications (under the tongue), intramuscular injections, and skin patches, among others
Bacteriostatic water itself causes very few side effects
Additionally, BPC-157 modulates the nitric oxide system: at low doses it appears to stimulate NO production via eNOS, while simultaneously protecting against NO-mediated toxicity